Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystems Will Use AnVil Systems To Find Predicted Genes

NEW YORK, June 12-AnVil and Applied Biosystems will work together on a gene validation project that seeks to verify genes that have been predicted but not yet identified.


AnVil will apply its visualization and analysis tools to the database of human genome information developed by Celera Genomics that is now held by Applied Biosystems.


The project seeks to resolve how many of these potential genes are actual coding regions, potentially providing new insight into the total number of human genes.


"All signs seem to indicate that these genes exist, but there is not enough information to be conclusive," said AnVil marketing director William Wiegler. "ABI is looking for additional tools and expertise to analyze the data and come to more conclusive results. That's where we fit in."

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.